Pharmafile Logo
Pharmafocus logo
Advanced Search
Ikervis

New treatments to boost dry eye drug market – if approved

November 5, 2015
Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast

The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …

News
eye

Featured market report: Summary of dry eye syndrome

November 5, 2015
dry eye disease, dry eye syndrome, lifitegrast

This report provides the current prevalent population for dry eye syndrome across seven major markets.It includes data for the USA, …

Feature
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015
Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …

News
OECD logo

OECD report warns of high spend and slow growth for pharma industry

November 5, 2015
Manufacturing and Production, Sales and Marketing OECD, pharmaceutical spending

The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …

News
President Obama

Obama government launches drug price crackdown

November 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access

President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …

News

NHS England reinstates treatments to Cancer Drugs Fund

November 4, 2015
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NHS England

Five treatments in seven indications have been reinstated to Cancer Drugs Fund, as a result of negotiations between pharma companies …

News
Novo Nordisk building

Novo Nordisk invests in new insulin-filling facility

November 4, 2015
Manufacturing and Production Denmark, Novo Nordisk, manufacturing, production

Novo Nordisk is investing 2.1 billion Danish Kroner (about £200m) in a new facility in Hillerød, Denmark, which will produce diabetes …

News
lradvanyi_2

Merck appoints Laszlo Radvanyi as head of global immuno-oncology research

November 4, 2015
Research and Development Laszlo Radvanyi, Merck

Dr Laszlo Radvanyi has joined Merck as senior vice president and head of research in immuno-oncology.  The Merck Group says …

Appointment
GSK logo

GSK plots return to growth with launch of 20 new drugs by 2020

November 4, 2015
Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline

GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …

News
researchers examining test tube

Drugs later in development ‘winning the race to market’

November 4, 2015
Research and Development R&D, drug approval, drug development, market exclusivity

Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …

News
Andrew Witty GSK

Pfizer approached GSK for takeover before Allergan

November 4, 2015
Research and Development, Sales and Marketing Allergan, GSK, Pfizer, financial results, product pipeline

Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …

News
BMS building

Bristol-Myers Squibb enters academic R&D tie-up

November 4, 2015
Research and Development BMS, Bristol-Myers Squibb, Cardioxy, John Hopkins, acquisition, immunooncology, job losses

Bristol-Myers Squibb and The Johns Hopkins University have entered into a collaboration agreement, as part of the pharma firm’s rare …

News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015
Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …

News
Prof Paul Workman

Putting off-patent drugs back to work

November 4, 2015
Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents

Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …

Feature
GSK building

GSK and Merck to study immunotherapy combo in solid tumours

November 3, 2015
Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I

GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …

News
paul_oliver_cfo_biocity

Pharma R&D hub BioCity appoints new CFO

November 3, 2015
Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver

BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …

Appointment

Sanofi claims $109m impact on revenue following recall

November 3, 2015
Manufacturing and Production Sanofi, finance, maufacturing, product recall

As Sanofi recalls its Auvi-Q epinephrine injection for the treatment of severe allergic reactions – after the company found the …

News
Europe Member State flags

EU plans export waiver for pharma manufacturing

November 3, 2015
Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates

The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …

News
R&D

Sanofi and BioNTech in cancer immunotherapy partnership

November 3, 2015
Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy

Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …

News

Mylan appoints a global commercial lead for OTC business

November 3, 2015
Manufacturing and Production Mylan, OTC, Ranjan Ray Chaudhuri, over the counter

Mylan has appointed Ranjan Ray Chaudhuri as its new global commercial lead for the company’s over-the-counter (OTC) business. Chaudhuri will …

Appointment
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026